SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001842612-23-000008
Filing Date
2023-06-13
Accepted
2023-06-13 21:11:27
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 158641
2 ACKNOWLEDGMENT millerpoa1.pdf EX-24 114867
  Complete submission text file 0001842612-23-000008.txt   318756
Mailing Address C/O JAZZ PHARMACEUTICALS PLC 5TH FL, WATERLOO EXCHANGE, WATERLOO RD DUBLIN 4 L2
Business Address C/O JAZZ PHARMACEUTICALS PLC 5TH FL, WATERLOO EXCHANGE, WATERLOO RD DUBLIN 4 L2 6504963552
MILLER MICHAEL PATRICK (Reporting) CIK: 0001236514 (see all company filings)

IRS No.: 000000000
Type: 144

Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Subject) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-35703 | Film No.: 231012804
SIC: 2834 Pharmaceutical Preparations